W. Wallace Harrington

Adipose Tissue Resistin Expression Is Severely Suppressed in Obesity and Stimulated by Peroxisome Proliferator-activated Receptor γ Agonists

James M. Way, Cem Z. Görgün, Qiang Tong et al. · Journal of Biological Chemistry · 2001 · 411 citations · Full text

Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor γ Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues

James M. Way, W. Wallace Harrington, Kathleen K. Brown et al. · Endocrinology · 2001 · 343 citations · Full text

Genetics, Insulin Signaling, Metabolic Syndrome +17

<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents

Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen et al. · Journal of Medicinal Chemistry · 1998 · 299 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Heterocycle Chemistry +17

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Kathleen K. Brown, Brad R. Henke, Steven G. Blanchard et al. · Diabetes · 1999 · 168 citations

Insulin Signaling, Peroxisome Proliferator-activated Receptor, Metabolic Syndrome +16

High-affinity neuropeptide Y receptor antagonists.

Alex J. Daniels, Jessica Matthews, Ruta Slepetis et al. · Proceedings of the National Academy of Sciences · 1995 · 139 citations · Full text

Neuropeptides, Sympathetic Nerve Terminals, Pharmacotherapy +18